chr12-49041018-G-A

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_003482.4(KMT2D):​c.6752C>T​(p.Ser2251Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00164 in 1,582,118 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. S2251S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0020 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 7 hom. )

Consequence

KMT2D
NM_003482.4 missense

Scores

1
9
7

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:6O:1

Conservation

PhyloP100: 6.28
Variant links:
Genes affected
KMT2D (HGNC:7133): (lysine methyltransferase 2D) The protein encoded by this gene is a histone methyltransferase that methylates the Lys-4 position of histone H3. The encoded protein is part of a large protein complex called ASCOM, which has been shown to be a transcriptional regulator of the beta-globin and estrogen receptor genes. Mutations in this gene have been shown to be a cause of Kabuki syndrome. [provided by RefSeq, Oct 2010]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.008974552).
BP6
Variant 12-49041018-G-A is Benign according to our data. Variant chr12-49041018-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 94242.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=1, not_provided=1, Likely_benign=1, Benign=5}. Variant chr12-49041018-G-A is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00195 (297/152260) while in subpopulation AMR AF = 0.0114 (175/15300). AF 95% confidence interval is 0.0101. There are 1 homozygotes in GnomAd4. There are 159 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position FAILED quality control check.
BS2
High AC in GnomAd4 at 297 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KMT2DNM_003482.4 linkc.6752C>T p.Ser2251Leu missense_variant Exon 32 of 55 ENST00000301067.12 NP_003473.3 O14686-1Q59FG6Q6PIA1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KMT2DENST00000301067.12 linkc.6752C>T p.Ser2251Leu missense_variant Exon 32 of 55 5 NM_003482.4 ENSP00000301067.7 O14686-1

Frequencies

GnomAD3 genomes
AF:
0.00195
AC:
297
AN:
152142
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00220
Gnomad AMR
AF:
0.0115
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00128
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00242
AC:
542
AN:
224340
AF XY:
0.00206
show subpopulations
Gnomad AFR exome
AF:
0.000461
Gnomad AMR exome
AF:
0.0123
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000101
Gnomad NFE exome
AF:
0.00142
Gnomad OTH exome
AF:
0.000750
GnomAD4 exome
AF:
0.00161
AC:
2300
AN:
1429858
Hom.:
7
Cov.:
35
AF XY:
0.00148
AC XY:
1045
AN XY:
707914
show subpopulations
Gnomad4 AFR exome
AF:
0.000524
AC:
17
AN:
32466
Gnomad4 AMR exome
AF:
0.0122
AC:
501
AN:
41142
Gnomad4 ASJ exome
AF:
0.00
AC:
0
AN:
23724
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39398
Gnomad4 SAS exome
AF:
0.00
AC:
0
AN:
81654
Gnomad4 FIN exome
AF:
0.000153
AC:
8
AN:
52150
Gnomad4 NFE exome
AF:
0.00155
AC:
1701
AN:
1094902
Gnomad4 Remaining exome
AF:
0.00124
AC:
73
AN:
58832
Heterozygous variant carriers
0
134
268
401
535
669
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
76
152
228
304
380
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00195
AC:
297
AN:
152260
Hom.:
1
Cov.:
32
AF XY:
0.00214
AC XY:
159
AN XY:
74452
show subpopulations
Gnomad4 AFR
AF:
0.000650
AC:
0.000649663
AN:
0.000649663
Gnomad4 AMR
AF:
0.0114
AC:
0.0114379
AN:
0.0114379
Gnomad4 ASJ
AF:
0.00
AC:
0
AN:
0
Gnomad4 EAS
AF:
0.000194
AC:
0.000193723
AN:
0.000193723
Gnomad4 SAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 FIN
AF:
0.000188
AC:
0.000188288
AN:
0.000188288
Gnomad4 NFE
AF:
0.00128
AC:
0.00127937
AN:
0.00127937
Gnomad4 OTH
AF:
0.00142
AC:
0.00142045
AN:
0.00142045
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00141
Hom.:
1
Bravo
AF:
0.00247
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00156
AC:
6
ESP6500AA
AF:
0.000781
AC:
3
ESP6500EA
AF:
0.000486
AC:
4
ExAC
AF:
0.00180
AC:
218
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:6Other:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:3
Oct 16, 2018
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 14, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 28933623) -

Jan 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

KMT2D: BS1 -

not specified Benign:2Other:1
Jan 02, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Kabuki syndrome 1 Uncertain:1
Nov 01, 2016
Center for Human Genetics, Inc, Center for Human Genetics, Inc
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Kabuki syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.30
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.090
CADD
Uncertain
23
DANN
Uncertain
0.98
DEOGEN2
Benign
0.23
T
Eigen
Uncertain
0.62
Eigen_PC
Uncertain
0.66
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.88
D
MetaRNN
Benign
0.0090
T
MetaSVM
Uncertain
0.086
D
MutationAssessor
Benign
0.55
N
PrimateAI
Uncertain
0.72
T
PROVEAN
Uncertain
-2.4
N
REVEL
Uncertain
0.41
Sift
Uncertain
0.0010
D
Polyphen
1.0
D
Vest4
0.56
MVP
0.47
MPC
0.60
ClinPred
0.025
T
GERP RS
5.1
Varity_R
0.21
gMVP
0.19
Mutation Taster
=87/13
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs189199944; hg19: chr12-49434801; COSMIC: COSV104396890; API